Although glycogen synthase kinase 3beta (GSK3beta) is emerging as a prominent drug target in the treatment of neurodegenerative diseases such as Alzheimer's disease (AD) and stroke, very little is known about age-related changes in GSK3beta expression and GSK3beta phosphorylation. Therefore, we examined age-related changes in immunoreactivities for GSK3beta and phosphorylated GSK3beta (pGSK3beta) in the central nervous system. In aged rats, there were significant increases in GSK3beta immunoreactivity in the cell bodies and processes of pyramidal cells in most cortical regions. GSK3beta immunoreactivity was also significantly increased in the pyramidal layer of CA1-3 regions, and the granule cell layer of dentate gyrus. Age-related increase...
Glycogen synthase kinase-3beta (GSK3beta) is highly abundant in the brain. Various biochemical analy...
In this immunohistochemical study, the age- and stage-dependent accumulation of advanced glycation e...
The observed age-related decline in neurogenesis may result from reduced proliferation or increased ...
Glycogen synthase kinase-3 (GSK-3) is a constitutively active kinase, involved in regulation of mult...
Glycogen synthase kinase-3beta (GSK-3beta) is a physiological kinase for tau and is a candidate prot...
Alzheimer's disease (AD) is a disorder without a molecular marker in peripheral tissues or a disease...
Adult hippocampal neurogenesis (AHN) is crucial for the maintenance of hippocampal function. Several...
Alzheimer disease (AD) is the most common form of age-related dementia. The etiology of AD is consid...
Alzheimer’s Disease (AD) is characterized by development of beta amyloid (Aβ) plaques and hyper-phos...
The PI3K-dependent activation of AKT results in the inhibition of GSK3β in most signaling pathways. ...
The disruption of glycogen synthase kinase 3-beta (GSK3B) homeostasis has implications in the pathop...
As a constitutively active kinase, glycogen synthase kinase 3 (GSK3) is a kinase which regulates bod...
Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase originally identified as a regulator...
The pathogenesis of diabetic neurological complications is not fully understood. Diabetes mellitus (...
<div><p>The PI3K-dependent activation of AKT results in the inhibition of GSK3β in most signaling pa...
Glycogen synthase kinase-3beta (GSK3beta) is highly abundant in the brain. Various biochemical analy...
In this immunohistochemical study, the age- and stage-dependent accumulation of advanced glycation e...
The observed age-related decline in neurogenesis may result from reduced proliferation or increased ...
Glycogen synthase kinase-3 (GSK-3) is a constitutively active kinase, involved in regulation of mult...
Glycogen synthase kinase-3beta (GSK-3beta) is a physiological kinase for tau and is a candidate prot...
Alzheimer's disease (AD) is a disorder without a molecular marker in peripheral tissues or a disease...
Adult hippocampal neurogenesis (AHN) is crucial for the maintenance of hippocampal function. Several...
Alzheimer disease (AD) is the most common form of age-related dementia. The etiology of AD is consid...
Alzheimer’s Disease (AD) is characterized by development of beta amyloid (Aβ) plaques and hyper-phos...
The PI3K-dependent activation of AKT results in the inhibition of GSK3β in most signaling pathways. ...
The disruption of glycogen synthase kinase 3-beta (GSK3B) homeostasis has implications in the pathop...
As a constitutively active kinase, glycogen synthase kinase 3 (GSK3) is a kinase which regulates bod...
Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase originally identified as a regulator...
The pathogenesis of diabetic neurological complications is not fully understood. Diabetes mellitus (...
<div><p>The PI3K-dependent activation of AKT results in the inhibition of GSK3β in most signaling pa...
Glycogen synthase kinase-3beta (GSK3beta) is highly abundant in the brain. Various biochemical analy...
In this immunohistochemical study, the age- and stage-dependent accumulation of advanced glycation e...
The observed age-related decline in neurogenesis may result from reduced proliferation or increased ...